Embryonic osteocalcin signaling determines lifelong adrenal steroidogenesis and homeostasis in the mouse.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
    • Publication Information:
      Publication: 1999- : Ann Arbor, MI : American Society for Clinical Investigation
      Original Publication: New Haven [etc.] American Society for Clinical Investigation.
    • Subject Terms:
    • Abstract:
      Through their ability to regulate gene expression in most organs, glucocorticoid (GC) hormones influence numerous physiological processes and are therefore key regulators of organismal homeostasis. In bone, GC hormones inhibit expression of the hormone Osteocalcin for poorly understood reasons. Here, we show that in a classical endocrine feedback loop, osteocalcin in return enhanced the biosynthesis of GC as well as mineralocorticoid hormones (adrenal steroidogenesis) in rodents and primates. Conversely, inactivation of osteocalcin signaling in adrenal glands significantly impaired adrenal growth and steroidogenesis in mice. Embryo-made osteocalcin was necessary for normal Sf1 expression in fetal adrenal cells and adrenal cell steroidogenic differentiation and therefore determined the number of steroidogenic cells present in the adrenal glands of adult animals. Embryonic, not postnatal, osteocalcin also governed adrenal growth, adrenal steroidogenesis, blood pressure, electrolyte equilibrium, and the rise in circulating corticosterone levels during the acute stress response in adult offspring. This osteocalcin-dependent regulation of adrenal development and steroidogenesis occurred even in the absence of a functional hypothalamus/pituitary/adrenal axis and explains why osteocalcin administration during pregnancy promoted adrenal growth and steroidogenesis and improved the survival of adrenocorticotropic hormone signaling-deficient animals. This study reveals that a bone-derived embryonic hormone influences lifelong adrenal functions and organismal homeostasis in the mouse.
    • Comments:
      Comment in: Nat Rev Endocrinol. 2022 Mar;18(3):135. (PMID: 34992234)
      Comment in: J Clin Invest. 2022 Feb 15;132(4):. (PMID: 35166237)
    • References:
      J Bone Miner Res. 2021 Sep;36(9):1694-1707. (PMID: 33956999)
      Cell. 2013 Sep 26;155(1):228-41. (PMID: 24074871)
      Br J Pharmacol. 2011 May;163(1):29-43. (PMID: 21198556)
      Nature. 2012 Jan 18;481(7381):314-20. (PMID: 22258610)
      Proc Natl Acad Sci U S A. 2018 Dec 26;115(52):E12265-E12274. (PMID: 30541888)
      Bone. 2007 May;40(5):1190-5. (PMID: 17276744)
      Mol Endocrinol. 2004 Apr;18(4):941-52. (PMID: 14726490)
      Front Endocrinol (Lausanne). 2015 Mar 05;6:27. (PMID: 25798129)
      Endocrinology. 2021 Apr 1;162(4):. (PMID: 33474566)
      Anat Embryol (Berl). 2006 Mar;211(2):109-17. (PMID: 16463171)
      Annu Rev Med. 2010;61:91-104. (PMID: 20059333)
      Gen Comp Endocrinol. 2008 May 1;156(3):441-53. (PMID: 18359027)
      Genesis. 2006 Sep;44(9):419-24. (PMID: 16937416)
      Endocrinol Metab Clin North Am. 2015 Jun;44(2):243-74. (PMID: 26038200)
      Genes Dev. 2019 Feb 1;33(3-4):209-220. (PMID: 30692207)
      Mol Cell Endocrinol. 2012 Mar 24;350(2):151-62. (PMID: 21839803)
      Sci Rep. 2020 Jul 7;10(1):11143. (PMID: 32636482)
      Cell. 2011 Mar 4;144(5):796-809. (PMID: 21333348)
      Nature. 2020 May;581(7809):434-443. (PMID: 32461654)
      Cell. 2007 Aug 10;130(3):456-69. (PMID: 17693256)
      Cell Metab. 2016 Jun 14;23(6):1078-1092. (PMID: 27304508)
      Cell. 2016 Mar 10;164(6):1248-1256. (PMID: 26967290)
      Nature. 1996 Aug 1;382(6590):448-52. (PMID: 8684484)
      Nat Rev Endocrinol. 2021 Jul;17(7):421-434. (PMID: 34011989)
      Cell Rep. 2018 Dec 18;25(12):3299-3314.e6. (PMID: 30566858)
      Pediatr Res. 2007 Mar;61(3):366-70. (PMID: 17314699)
      Cell Metab. 2019 Nov 5;30(5):890-902.e8. (PMID: 31523009)
      Endocrinology. 2005 Jun;146(6):2555-62. (PMID: 15731356)
      Methods Mol Biol. 2009;573:45-55. (PMID: 19763921)
      Exp Mol Med. 2014 May 02;46:e93. (PMID: 24787734)
      Genes Dev. 2016 Jun 15;30(12):1389-94. (PMID: 27313319)
      J Endocr Soc. 2020 Jun 29;4(9):bvaa075. (PMID: 32783015)
      J Exp Med. 2017 Oct 2;214(10):2859-2873. (PMID: 28851741)
      Nat Commun. 2016 Sep 14;7:12751. (PMID: 27624192)
      Dev Cell. 2013 Sep 30;26(6):666-673. (PMID: 24035414)
      Proc Natl Acad Sci U S A. 2007 Nov 13;104(46):18205-10. (PMID: 17989225)
      Endocr Res. 1984-1985;10(3-4):213-42. (PMID: 6100243)
      Endocr Pract. 2016 Dec;22(12):1415-1421. (PMID: 27540879)
      J Clin Endocrinol Metab. 2005 Sep;90(9):5500-1. (PMID: 16148348)
      Biochem Biophys Res Commun. 2010 Jul 9;397(4):691-6. (PMID: 20570657)
    • Grant Information:
      P01 AG032959 United States AG NIA NIH HHS; R01 HD107574 United States HD NICHD NIH HHS
    • Contributed Indexing:
      Keywords: Bone Biology; Metabolism; Mouse models
    • Accession Number:
      0 (Glucocorticoids)
      104982-03-8 (Osteocalcin)
    • Publication Date:
      Date Created: 20211214 Date Completed: 20220328 Latest Revision: 20220328
    • Publication Date:
      20240105
    • Accession Number:
      PMC8843753
    • Accession Number:
      10.1172/JCI153752
    • Accession Number:
      34905510